MIT and Mass General Brigham launch joint seed program to accelerate innovations in health
The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.
The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.
Researchers find nonclinical information in patient messages — like typos, extra white space, and colorful language — reduces the accuracy of an AI model.
Courses on developing AI models for health care need to focus more on identifying and addressing bias, says Leo Anthony Celi.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
Words like “no” and “not” can cause this popular class of AI models to fail unexpectedly in high-stakes settings, such as medical diagnosis.
A new book coauthored by MIT’s Dimitris Bertsimas explores how analytics is driving decisions and outcomes in health care.
A new method helps convey uncertainty more precisely, which could give researchers and medical clinicians better information to make decisions.
Ultraviolet light “fingerprints” on cell cultures and machine learning can provide a definitive yes/no contamination assessment within 30 minutes.
A new method lets users ask, in plain language, for a new molecule with certain properties, and receive a detailed description of how to synthesize it.
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.